Algeria Pharmaceuticals & Healthcare Report Q1 2016 - New Market Report

While the effects of global oil prices slump will slowdown Algeria's public and private spending growth rates over a multi-quarter horizon, the government will keep among its priorities the modernisation of healthcare facilities and the expansion of drug manufacturing capacities. Indeed, while we forecast a sharp decline in pharmaceutical imports in 2015, we expect import growth to pick up from 2016 onwards, albeit at a slower pace than in previous years, reflecting the expansion of local manufacturing capabilities as well as import restrictions. However, the growing demand for pharmaceuticals will not be sufficiently covered by local production, with the import of high-end products to grow as consumer affordability levels increase in line with economic improvement.

Full Report Details at
- http://www.fastmr.com/prod/1063166_algeria_pharmaceuticals.aspx?afid=301

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Australia Pharmaceuticals & Healthcare Report Q1 2016
- Slovenia Pharmaceuticals & Healthcare Report Q1 2016
- Croatia Pharmaceuticals & Healthcare Report Q1 2016
- Puerto Rico Pharmaceuticals & Healthcare Report Q1 2016
- Estonia Pharmaceuticals & Healthcare Report Q4 2015